NCT07098104 2025-08-01A Benefit Population Atlas of nICT Versus nCT for LAGCJiangsu Cancer Institute & HospitalCompleted291 enrolled
NCT03745170 2023-03-01Efficacy and Safety Evaluation of Sintilimab or Placebo in Combination With XELOX as First Line Treatment in Patients With Gastric CancerInnovent Biologics (Suzhou) Co. Ltd.Phase 3 Completed650 enrolled